In a collaboration that promises to accelerate cutting-edge research and foster tomorrow’s medical discoveries, Stony Brook Medicine and Mount Sinai Health System have entered into an affiliation agreement aimed at heightening research collaboration and enhancing academic programs and clinical care initiatives.

“This is a momentous day for academic medicine, health care, our respective students, faculty and staff, and for all those who are cared for by our teams of highly trained, dedicated clinicians,” said Stony Brook University President Samuel L. Stanley Jr., MD. “Each institution has so much to offer, so this is an opportunity that will prove to be beneficial for all — now and in the future — as we explore and grow this incredible collaboration.”

“The opportunities for amazing science to spring from our collaborative efforts are truly boundless,” said Kenneth Kaushansky, MD, Senior Vice President for Health Sciences, and Dean of the Stony Brook University School of Medicine. “When you bring the intellectual and biomedical horsepower of the Icahn School of Medicine faculty together with the outstanding neuroscientists, cancer biologists, imaging innovators, cardiovascular experts, and leading biomedical informaticists of the Stony Brook School of Medicine, as well as the world-class departments of computer sciences, biomedical engineering, chemistry, and applied mathematics at Stony Brook University, the possibilities are staggering.”
Add comment